ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of Two Diets for Weight and Diabetes Management (Two-for-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00729196
Recruitment Status : Completed
First Posted : August 7, 2008
Last Update Posted : February 1, 2011
Sponsor:
Collaborator:
University of Pennsylvania
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Brief Summary:
The purpose of this study is to determine whether a low-fat or low-glycemic load diet is more effective for controlling weight and blood glucose in persons with type 2 diabetes.

Condition or disease Intervention/treatment Phase
Type 2 Diabetes Mellitus Obesity Behavioral: Lifestyle Modification Not Applicable

Detailed Description:
This research is a randomized controlled trial to compare long-term outcomes behavioral weight loss interventions that include either low-fat or low-glycemic load dietary instruction. Targets for energy intake and expenditure, and behavioral skills taught, are identical across the two diets. Additionally, both treatments include 20 weekly group sessions, followed by 10 every-other-week sessions. Participants are overweight and obese adults with type 2 diabetes. The primary outcomes are changes in weight and glycated hemoglobin. Those randomized to the low-glycemic load diet are expected to achieve greater weight losses and maintain better glycemic control at the end of treatment (i.e., week 40) and after 1 year of no-treatment follow-up (i.e., week 92).

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Trial of Two Diets for Weight and Diabetes Management
Study Start Date : July 2005
Actual Primary Completion Date : May 2010
Actual Study Completion Date : June 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Body Weight
U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Low-Glycemic Load Diet
Behavioral: Lifestyle Modification
Weekly group therapy for 20 weeks, followed by bi-weekly group therapy for 20 weeks
Active Comparator: 2
Low-Fat Diet
Behavioral: Lifestyle Modification
Weekly group therapy for 20 weeks, followed by bi-weekly group therapy for 20 weeks



Primary Outcome Measures :
  1. Percent change in weight [ Time Frame: 92 weeks ]

Secondary Outcome Measures :
  1. Change in HbA1c [ Time Frame: 92 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Type 2 Diabetes Mellitus
  • Body mass index (BMI) of 27 to 45 kg/m2 with weight </= 136 kg (300 lbs.
  • Capacity to provide written informed consent
  • Systolic blood pressure between 90 and 160 mm Hg, inclusive.
  • Diastolic blood pressure between 65 and 100 mm Hg, inclusive.
  • Resting heart rate between 65 and 90 beats per minute, inclusive.

Exclusion Criteria:

  • a recent (i.e., within 1 year) myocardial infarction
  • unstable angina
  • malignant arrhythmias
  • history of cerebrovascular, renal, or hepatic disease
  • history of seizures
  • protein wasting diseases (e.g., Cushing's syndrome)
  • uncontrolled hypertension (> 160/100 mm Hg)
  • type 1 diabetes
  • uncontrolled thyroid disease
  • pregnancy or lactation
  • electrolyte abnormalities
  • clinically significant psychosocial impairment (principally, major depression)
  • treatment with steroids

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00729196


Locations
United States, Pennsylvania
University of Pennsylvania, Center for Weight and Eating Disorders
Philadelphia, Pennsylvania, United States, 19104-3309
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Pennsylvania
Investigators
Principal Investigator: Anthony N Fabricatore, Ph.D. University of Pennsylvania
Study Director: Thomas A Wadden, Ph.D. University of Pennsylvania
Study Director: Virginia A Stallings, M.D. Children's Hospital of Philadelphia
Study Director: Stanley Schwartz, M.D. University of Pennsylvania

Responsible Party: Anthony N. Fabricatore, University of Pennsylvania
ClinicalTrials.gov Identifier: NCT00729196     History of Changes
Other Study ID Numbers: K23 DK70777 (completed)
K23DK070777 ( U.S. NIH Grant/Contract )
First Posted: August 7, 2008    Key Record Dates
Last Update Posted: February 1, 2011
Last Verified: January 2011

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Obesity
Type 2 Diabetes
Glycemic Load
Weight Loss
Glycated Hemoglobin

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases